How to note the diagnosis
Ex. cervical pain without radicular pain from discal disorder. 
LOWER LIMB PAIN (LOCAL SYNDROMES)
9.1 Ischial bursitis 9.2 Trochanteric bursitis 9.3 Osteoarthritis of the hip 9.4 Osteoarthritis of the knee 9.5 Plantar fasciitis 9.6 Sciatica neuralgia 9.7 Obturator neuralgia 9.8 Femoral neuralgia 9.9 Piriformis syndrome 9.10 Plexopathy 9.11 Acute herpes zoster 9.12 Postherpetic neuralgia 9.13 Diabetic neuropathy 9.14 Other peripheral neuropathy 9a mononeuropathy 9b polyneuropathy 9.15 Complex regional pain syndrome 9.16 Postphlebetic pain syndrome 9.17 Stump pain 9.18 Phantom pain 9.19 Myofascial pain (trigger point) 9.20 Restless leg syndrome 9.21 Traumatic origin 9.22 Following surgery 9.23 Associated with a neoplasm 9.24 Following cancer treatment (chemotherapy/radiotherapy) 9.25 Following HIV and/or its treatment 9.26 Uncertain origin 9.27 Other: 
HEAD AND FACE PAINFUL SYNDROMES

I. Context
The Quebec Pain Registry ("Registry) is an administrative and research database of chronic pain patients who are treated in tertiary care pain clinics. The Registry uses common demographics, identical clinical descriptions and uniform, validated and standardized measurement tools that may be used in evaluating and promoting evidence-based standards of care. The database is available to facilitate and stimulate clinical pain research for both academia and industry, and to provide a greater understanding of the impact of chronic pain on society. The Registry wishes to allow members of the scientific community access and use of the data to carry out epidemiological, evaluative or clinical research. The Registry can also be used for clinicaladministrative purposes by clinicians working at one of the sites participating in the QPR and who are involved in data collection.
II. Objective
The Quebec Pain Registry -Access Policy (QPR -Access Policy) is to oversee applications to be made by researchers or clinicians wishing to use data (QPR -Data Requests). To be authorized, such use must be made in accordance and in compliance with this QPR -Access Policy ("Policy").
III. Conditions for Use of Registry Data
Access and use of QPR data should made in compliance with the following conditions: i. Ensure protection of the privacy of the Registry participants. Personal information is confidential. No access to non-anonymized data will be granted except under strict rules approved by the Ethics Committee of the institutions affiliated to the participating sites.
ii. The data are available to persons who carry out research activities, both in the academic sector (e.g.: Universities and Research Institutes) and in the private sector (industry). Data results cannot be sold to another organization. The data are also available to clinicians and policy makers for clinical-administrative purposes.
iii. Before access is granted to the Registry, the application along with the research protocol must obtain approval from the Scientific Review Committee (SRC) by submitting the QPR -Data Request Form. Once approved, any substantive change in the request that the applicant wishes to make must be transmitted to the SRC. Changes in data required will be handled as separate request. Clinicians who wish to access QPR Data must submit the QPR -Data Request Form and obtain approval from the Principal Investigators (PIs) of the QPR (Dr Manon Choinière from the Centre de recherche du Centre hospitalier de l'Université de Montréal and Dr Mark Ware from the Research Institute of the McGill University Health Centre)
All information relating to any access request will be kept confidential unless the applicant provides a written authorization that part of the information can be posted on the Registry website. This information may include name and institution of the applicant, title of the project and non-technical summary of the project.
IV. Scientific Review Committee
The Registry has created a Scientific Review Committee (SRC) and gives this committee the mandate to ensure respect for the QPR -Access Policy with respect to any request and use of data, and to ensure its scientific integrity. Currently, the SRC is composed of the PIs of the Registry and additional members are included when required.
V. Processing a Request
i.
The applicant who wishes to have access to QPR data must make a written request to the Registry using the QPR -Data Request Form which must be approved and signed by the SRC.
ii. Application for access is considered "under review" until it is determined if the data or reports can be available according to the SRC criteria set in accordance with Registry objectives.
iii.
The SRC recognizes that reviews of requests should be conducted in a timely manner.
iv.
A decision in favor of the request will be followed by the applicant's review and signature of the "QPR -Access Agreement" which is counter-signed by a representative of the SRC.
v. A decision to deny or delay access to the Registry may include suggestions to the applicant of changes that could bring the request for access or use to a favorable decision.
vi. If the request should involve the collection of new variables not contained in the Registry ("Satellite Research Project") , the QPR -Data Request Form signed by both parties along with the research protocol will have to be submitted by the Researcher for review and approval by the Scientific and Ethics Committees of the Centre hospitalier de l'Université de Montréal) and the local institutional committees of the QPR participating sites.
VI. Criteria for Evaluation of a Request
The SRC must evaluate all requests for access with the following criteria: i.
Compliance with the terms and conditions listed in Section III (Conditions for use of data)
ii.
The scientific quality of the research project for which the application is associated, including;
a. The validity of the hypothesis; b. The objectives of the research project; c. The proposed methodology; d. The purpose and intended use of data VII. Data Access, Use and Delivery i. Any applicant, whose request for access has been approved, will be provided with the "QPR -Fee Estimate" which will detail the costs and expected time frame of output.
If agreeable the applicant must complete and sign the standardized "QPR -Access Agreement" before any data extraction can begin.
ii. The arrangement for data transfer, prioritization and delivery timing will be finalized between the Registry data management staff and the applicant.
VIII. Publication 1
i. Applicants who have used or accessed data for research purposes are invited to present and/or publish the results of their project to the scientific community and the general public who may benefit from them. The researcher must state in its publications or presentations that the data used came from the Quebec Pain Registry (See Appendix 1 of the "QPR -Access Agreement" document).
ii. Data provided for clinical-administrative purposes cannot be used for research purposes and published (see Note 1 for definition of publication).
IX. Intellectual Property
The Registry does not claim any intellectual property rights on the results, discoveries, inventions or works that could result from a project research for which Registry data was used.
X. Costs
A non-refundable administration fee is required for any applicant (except clinicians) who submits a request for access. This cost is due when the request is submitted. This fee is to cover review costs and to discourage frivolous requests. It is only charged once per request.
